147 related articles for article (PubMed ID: 28409339)
41. Comparison of phosphorescent agents for noninvasive sensing of tumor oxygenation via Cherenkov-excited luminescence imaging.
Shell J; LaRochelle EP; Bruza P; Gunn J; Jarvis L; Gladstone D; Pogue B
J Biomed Opt; 2019 Mar; 24(3):1-8. PubMed ID: 30834723
[TBL] [Abstract][Full Text] [Related]
42. Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy.
Stieb S; Eleftheriou A; Warnock G; Guckenberger M; Riesterer O
Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2201-2217. PubMed ID: 30128659
[TBL] [Abstract][Full Text] [Related]
43. High Single Doses of Radiation May Induce Elevated Levels of Hypoxia in Early-Stage Non-Small Cell Lung Cancer Tumors.
Kelada OJ; Decker RH; Nath SK; Johung KL; Zheng MQ; Huang Y; Gallezot JD; Liu C; Carson RE; Oelfke U; Carlson DJ
Int J Radiat Oncol Biol Phys; 2018 Sep; 102(1):174-183. PubMed ID: 30102194
[TBL] [Abstract][Full Text] [Related]
44. Intracellular hypoxia measured by
Asano A; Ueda S; Kuji I; Yamane T; Takeuchi H; Hirokawa E; Sugitani I; Shimada H; Hasebe T; Osaki A; Saeki T
Breast Cancer Res; 2018 Jul; 20(1):78. PubMed ID: 30053906
[TBL] [Abstract][Full Text] [Related]
45. Overexpression of Receptor Tyrosine Kinase EphB4 Triggers Tumor Growth and Hypoxia in A375 Melanoma Xenografts: Insights from Multitracer Small Animal Imaging Experiments.
Neuber C; Belter B; Meister S; Hofheinz F; Bergmann R; Pietzsch HJ; Pietzsch J
Molecules; 2018 Feb; 23(2):. PubMed ID: 29462967
[TBL] [Abstract][Full Text] [Related]
46. FMISO as a Biomarker for Clinical Radiation Oncology.
Zschaeck S; Steinbach J; Troost EG
Recent Results Cancer Res; 2016; 198():189-201. PubMed ID: 27318688
[TBL] [Abstract][Full Text] [Related]
47. Quantification of Tumor Hypoxic Fractions Using Positron Emission Tomography with [
Kelada OJ; Rockwell S; Zheng MQ; Huang Y; Liu Y; Booth CJ; Decker RH; Oelfke U; Carson RE; Carlson DJ
Mol Imaging Biol; 2017 Dec; 19(6):893-902. PubMed ID: 28409339
[TBL] [Abstract][Full Text] [Related]
48. Pharmacokinetic Analysis of Dynamic
Schwartz J; Grkovski M; Rimner A; Schöder H; Zanzonico PB; Carlin SD; Staton KD; Humm JL; Nehmeh SA
J Nucl Med; 2017 Jun; 58(6):911-919. PubMed ID: 28232611
[TBL] [Abstract][Full Text] [Related]
49.
Grkovski M; Emmas SA; Carlin SD
J Nucl Med; 2017 Oct; 58(10):1567-1573. PubMed ID: 28360207
[TBL] [Abstract][Full Text] [Related]
50.
McGowan DR; Macpherson RE; Hackett SL; Liu D; Gleeson FV; McKenna WG; Higgins GS; Fenwick JD
Med Phys; 2017 Sep; 44(9):4665-4676. PubMed ID: 28644546
[TBL] [Abstract][Full Text] [Related]
51. Quantitative Analysis of [
Shi K; Bayer C; Astner ST; Gaertner FC; Vaupel P; Schwaiger M; Huang SC; Ziegler SI
Mol Imaging Biol; 2017 Feb; 19(1):120-129. PubMed ID: 27379986
[TBL] [Abstract][Full Text] [Related]
52.
Yu W; Qiao F; Su X; Zhang D; Wang H; Jiang J; Xu H
Biomed Pharmacother; 2019 Nov; 119():109454. PubMed ID: 31526971
[TBL] [Abstract][Full Text] [Related]
53. Synthesis of [(18)F]FMISO in a flow-through microfluidic reactor: Development and clinical application.
Zheng MQ; Collier L; Bois F; Kelada OJ; Hammond K; Ropchan J; Akula MR; Carlson DJ; Kabalka GW; Huang Y
Nucl Med Biol; 2015 Jun; 42(6):578-84. PubMed ID: 25779036
[TBL] [Abstract][Full Text] [Related]
54. Kinetic modeling in PET imaging of hypoxia.
Li F; Joergensen JT; Hansen AE; Kjaer A
Am J Nucl Med Mol Imaging; 2014; 4(6):490-506. PubMed ID: 25250200
[TBL] [Abstract][Full Text] [Related]
55. Molecular imaging of tumor hypoxia with positron emission tomography.
Kelada OJ; Carlson DJ
Radiat Res; 2014 Apr; 181(4):335-49. PubMed ID: 24673257
[TBL] [Abstract][Full Text] [Related]
56.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
57.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
58.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
59.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
60.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
